Cargando…
Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing
INTRODUCTION: Altered splicing landscape is an emerging cancer hallmark; however, the dysregulation and implication of the cellular machinery controlling this process (spliceosome components and splicing factors) in hepatocellular carcinoma (HCC) is poorly known. This study aimed to comprehensively...
Autores principales: | López‐Cánovas, Juan L., Hermán‐Sánchez, Natalia, Moreno‐Montilla, Maria Trinidad, del Rio‐Moreno, Mercedes, Alors‐Perez, Emilia, Sánchez‐Frias, Marina E., Amado, Víctor, Ciria, Rubén, Briceño, Javier, de la Mata, Manuel, Castaño, Justo P., Rodriguez‐Perálvarez, Manuel, Luque, Raúl M., Gahete, Manuel D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684617/ https://www.ncbi.nlm.nih.gov/pubmed/36419260 http://dx.doi.org/10.1002/ctm2.1102 |
Ejemplares similares
-
PRPF8 increases the aggressiveness of hepatocellular carcinoma by regulating FAK/AKT pathway via fibronectin 1 splicing
por: López-Cánovas, Juan L., et al.
Publicado: (2023) -
Ghrelin-O-Acyltransferase (GOAT) Enzyme as a Novel Potential Biomarker in Gastroenteropancreatic Neuroendocrine Tumors
por: Herrera-Martínez, Aura D., et al.
Publicado: (2018) -
Molecular and Clinical Implications of Somatostatin Receptor Profile and Somatostatin Analogues Treatment in Oral Cavity Squamous Cell Carcinoma
por: Sanjuan-Sanjuan, Alba, et al.
Publicado: (2021) -
Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal
por: Espejo-Cruz, María Lola, et al.
Publicado: (2021) -
Splicing alterations in pancreatic ductal adenocarcinoma: a new molecular landscape with translational potential
por: Alors-Pérez, Emilia, et al.
Publicado: (2023)